Trade Summary

6 days ago, Booth Bruce, serving as Dir at Kymera Therapeutics, Inc. (KYMR), sold 478,198 shares at $94.72 per share, for a total transaction value of $45,293,293.82. Following this transaction, Booth Bruce now holds 617,663 shares of KYMR.

This sale represents a 43.64% decrease in Booth Bruce's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 23, 2026 (accepted Jun 22, 9:01 PM ET), 6 days after the trade was made.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.